MSA - Multiple System Atrophy Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting msa - multiple system atrophy clinical trials across 5 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Leuven, Vlaams-Brabant, Belgium, Brescia, Italy, Copenhagen, Denmark. Updated daily from ClinicalTrials.gov.


MSA - Multiple System Atrophy Trials at a Glance

7 actively recruiting trials for msa - multiple system atrophy are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Leuven, Brescia, and Copenhagen. Lead sponsors running msa - multiple system atrophy studies include Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, MD Stem Cells, and Bastyr University.

Browse msa - multiple system atrophy trials by phase

About MSA - Multiple System Atrophy Clinical Trials

Looking for clinical trials for MSA - Multiple System Atrophy? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new MSA - Multiple System Atrophy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about MSA - Multiple System Atrophy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Invasive Home Ventilation in Denmark

Spinal Cord Injuries (SCI)Neuromuscular Diseases (NMD)MSA - Multiple System Atrophy+5 more
Rigshospitalet, Denmark450 enrolled1 locationNCT07467187
Recruiting
Not Applicable

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

PSP - Progressive Supranuclear PalsyAlzheimer Dementia (AD)MSA - Multiple System Atrophy+7 more
Universitaire Ziekenhuizen KU Leuven300 enrolled1 locationNCT07509125
Recruiting

Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease

Parkinson DiseaseMSA - Multiple System AtrophyLewy Body Dementia (LBD)+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta180 enrolled3 locationsNCT06846658
Recruiting

The CurePSP Genetics Program

Multiple System Atrophy, Parkinsonian TypeMultiple System Atrophy, Cerebellar TypeMultiple System Atrophy+15 more
Massachusetts General Hospital1,000 enrolled1 locationNCT06647641
Recruiting
Not Applicable

Neurologic Stem Cell Treatment Study

Cognitive ImpairmentDementiaTraumatic Brain Injury+23 more
MD Stem Cells500 enrolled3 locationsNCT02795052
Recruiting
Phase 2Phase 3

[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD

Alzheimer DiseaseParkinson DiseaseDementia With Lewy Bodies+1 more
prof. dr. Koen Van Laere113 enrolled2 locationsNCT06120049
Recruiting

Modifiable Variables in Parkinsonism (MVP)

Corticobasal DegenerationDementia With Lewy BodiesProgressive Supranuclear Palsy+6 more
Bastyr University2,000 enrolled1 locationNCT02194816